| Samsung Bioepis CH GmbH - Imraldi 40 mg/0.4 ml, Injektionslösung in einer Fertigspritze | | 67427 | | 02 | | Imraldi 40 mg/0.4 ml | | Injektionslösung in einer Fertigspritze | | L04AB04 | | Adalimumab | | 18.12.2024 | | |
| | Composition | | adalimumabum 40 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, acidum succinicum, dinatrii succinas, histidinum, histidini hydrochloridum monohydricum, mannitolum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml corresp. natrium 0.08 mg. | | Packungsbestandteile | | Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Adalimumab | 40mg / 0.4ml |
| | BAG: Active Agent | Dose |
|---|
| Adalimumab | 40 mg |
| | | | Inactive agents |
|---|
| Succinic Acid | | Disodium Phosphate Heptahydrate | | | | Histidin Hydrochloride Monohydrate | | Histidine | | Mannitol | | Sodium Dihydrogenophosphate Monohydrate | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | | 371.10 | 419.95 | B | SL | No | | 005 | 2 | 742.20 | 823.50 | B | SL | No | | 006 | 6 | 2080.98 | 2281.00 | B | SL | No |
|
|
